Fatty liver disease is more common in people whose hearts don't change rate as much

Scientific Claim

Non-alcoholic fatty liver disease development is associated with reduced heart rate variability in adults

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

association

Can only show association/correlation

Assessment Explanation

The claim uses 'associated with' which is appropriate for an observational study. It correctly describes the relationship without implying causation.

Source Excerpt

“Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease”

Evidence from Studies

Supporting Evidence (1)

Why it supports

The study found an association between NAFLD development and lower HRV. The study design supports this correlational claim but cannot establish causation.

Score

Author Correction: Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease

Cannot Determine

Supported

Source Study

Author Correction: Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease

Score: 20

DOI: 10.1038/s41598-022-25977-7

Similar Assertions

People who don't already have liver problems but have lower heart rate variability are more likely to develop fatty liver disease later

99%

This connection between heart rate variability and fatty liver disease was found in a study with many participants followed over time

96%

People whose hearts don't change rate as much are more likely to develop fatty liver disease than people whose hearts change rate more

92%

People with lower heart rate variability (a measure of how much heart rate changes) from very short heart recordings are more likely to develop fatty liver disease later on

88%

A very quick heart rate measurement might help doctors identify people who are more likely to develop fatty liver disease in the future

83%